Slide background
Slide background




EudraBook Compendium of EU pharmaceutical law

ID 6831 | | Visite: 8259 | MedicinalPermalink: https://www.certifico.com/id/6831

EudraBook

EudraBook Compendium of EU pharmaceutical law

2015 marks the 50th anniversary of pharmaceutical legislation in the EU, which began with Directive 65/65 in 1965 in the wake of the Thalidomide disaster.

The EU legal framework for medicinal products for human use guarantees high standards of quality and safety of medicinal products and intends to promote the functioning of the internal market, with measures which encourage innovation and competiveness in Europe. It is based on the principle that medicinal products may be placed on the market only following a marketing authorisation granted by the competent authorities.

A large body of legislation has developed around this principle, with the progressive harmonisation of requirements for the granting of marketing authorisations since the 1960s, implemented across the whole European Economic Area.

Nowadays, medicinal products may be either authorised centrally by the European Commission or nationally by Member States’ competent authorities. The European Medicines Agency, established in 1995, underpins the centralised authorisation procedure and supports coordination between national competent authorities. The Agency is the hub of a European medicines network comprising over 40 national regulatory authorities guaranteeing a constant exchange and flow of information regarding the scientific assessment of medicinal products in the EU.

The EU legal framework is definitely not an area in which the law stands still. Quite the contrary, its history is marked by a constant ambition to improve its functioning or tackling shortcomings in order to guarantee the right balance between early access of patients to new medicines and high standards of quality and safety. Moreover, over the past 50 years science has developed. New technologies and further knowledge about diseases led to the introduction of new concepts or re-shaping of existing medical therapies that were subsequently mirrored in legislation.

The pharmaceutical sector is characterised by an abundance of guidelines intended to help and support the key players in the application of the EU legal framework. Still, the guidance documents would be nothing without the basic legislation on which they build.

To understand the EU legal framework for medicinal products it is important to know the applicable provisions of the legislation itself. This E-Book is intended to support readers in this regard by putting together the most recent versions of the key legal instruments on medicinal products for human use. It provides a useful overview for stakeholders, especially the pharmaceutical industry, regulatory authorities, legal practitioners, but also interested citizens, patients and healthcare professionals.

This E-Book reflects the law as it stands on 1 January 2015

Eudralex Ebook Version 1.3 06/05/2015

DescrizioneLinguaDimensioneDownloads
Scarica questo file (EudraBook Compendium of EU pharmaceutical law 2015.pdf)EudraBook Compendium of EU pharmaceutical law 2015
 
EN1558 kB768

Tags: Medicinal

Ultimi archiviati Chemicals

Nov 18, 2022 193

Regolamento delegato (UE) 2019/624

Regolamento delegato (UE) 2019/624 Regolamento delegato (UE) 2019/624 della Commissione, dell'8 febbraio 2019, recante norme specifiche per l'esecuzione dei controlli ufficiali sulla produzione di carni e per le zone di produzione e di stabulazione dei molluschi bivalvi vivi in conformità al… Leggi tutto
REACH Authorisation List
Nov 14, 2022 70

REACH Authorisation Decisions List: Last update 09.11.2022

REACH Authorisation Decisions List / Last update: 09.11.2022 REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regulation (EC) No 1907/2006 (REACH). The list also includes reference to related documentation concerning all applications for… Leggi tutto
Relazione sulle sostanze recuperate esentate dalla registrazione REACH
Nov 08, 2022 89

Relazione sulle sostanze recuperate esentate dalla registrazione REACH

Relazione sulle sostanze recuperate esentate dalla registrazione REACH Helsinki, 8 novembre 2022 / ECHA/NR/22/17 I risultati di un progetto pilota di applicazione del Forum sulle sostanze recuperate dai rifiuti rivelano che il 26 % delle sostanze controllate viola il regolamento REACH. Gli… Leggi tutto
Nov 07, 2022 269

Decreto 26 ottobre 2022

Decreto 26 ottobre 2022 / Scambio di informazioni non conformità prodotti biologici Misure e procedure documentate per consentire lo scambio di informazioni tra Autorita' competente e organismi di controllo ai sensi dell'articolo 9, paragrafo 6 del Reg. (UE) 2021/279 del 22 febbraio 2021 e… Leggi tutto
Relazione annuale ISIN 2022
Nov 02, 2022 102

Relazione annuale 2022 del Direttore dell’ISIN al Governo e al Parlamento

Relazione annuale 2022 del Direttore dell’ISIN al Governo e al Parlamento ISIN 28 Ottobre 2022 - Le attività svolte dall’Ispettorato e lo stato della sicurezza nucleare in Italia Sul sito dell’Ispettorato Nazionale per la Sicurezza Nucleare e la Radioprotezione è disponibile la Relazione annuale… Leggi tutto
REACH Authorisation List
Nov 02, 2022 96

REACH Authorisation Decisions List | Last update 28.10.2022

REACH Authorisation Decisions List / Last update: 28.10.2022 REACH Authorisation Decisions List of authorisation decisions adopted on the basis of Article 64 of Regulation (EC) No 1907/2006 (REACH). The list also includes reference to related documentation concerning all applications for… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Ott 24, 2022 71886

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto